MassIVE MSV000101009 - An orally active dual CBP/p300 degrader targets core dependencies of multiple myeloma
Fields of Study & Subjects
Protein Degradation and Inhibitors
Multiple Myeloma Research and Treatments
Histone Deacetylase Inhibitors Research
Publication details
- Journal / source
- UC San Diego
- Publication date
- 1 January 2026
- Language
- EN
- Document type
- Dataset